Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

BLVD Centers Launches Weedaide™ Website in Advance of Product Launch


Posted on: 14 Mar 18

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (“BLVD” or the “Company”) (TSXV:CXV), a leading company in the United States addiction recovery industry, today announced it has launched its website for the future sale of Weedaide™, its marijuana lifestyle management product line. The website can be found at www.weedaide.com and is available now for affiliate access.

The Company further announced that the Weedaide™ product line is expected to be available for sale in the coming weeks through the website and through other distribution mediums. The Weedaide™ product line consists of three products: Energy, Munchie Reducer, and Control. Each of which is designed around helping to reduce the side effects and cravings associated with recreational marijuana use. The website today is focused on recruiting affiliate marketers in advance of being able to sell Weedaide™ to consumers.

“I am excited to announce that our website is now available for access,” said Chris Heath, CEO. “We are looking forward to being able to leverage the website to build out an affiliate sales network ahead of the product becoming available in the next few weeks while we work to produce a sufficient quantity to meet expected demand. We are excited to begin working with our expected first round of affiliates and ensuring their success selling Weedaide™. Our goal is to ensure we have a robust network in place over the coming weeks for when product becomes available for sale. I am very optimistic based on the initial feedback we’ve seen, that Weedaide™ and similar offerings will be very accretive to the business.”

“I believe that this new, large and growing market offers an exceptional growth opportunity for the business,” continued Mr. Heath. “Our experience working with stakeholders in the market has continued to reaffirm my belief that the 80 million Americans eligible to use Marijuana recreationally will generate strong demand for the Weedaide™ line of products. I am greatly looking forward to being able to share initial reception and results with the markets shortly.”

Forward-Looking Statements

Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company, including: the Weedaide™ product line being available for sale in the coming weeks through the website and through other distribution mediums; that Weedaide™ and similar offerings will be accretive to the business; and that there will be strong demand for the Weedaide products; are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Material factors or assumptions were applied in providing forward-looking information, including: BLVD securing trademarks for its products; BLVD executing agreements with distributors and retailers for its products; no adverse changes to local, state and federal laws; and market reception of products. There is no guarantee that the Company’s plans to (i) sell products designed to reduce the side effects of daily marijuana use, (ii) generate significant revenue through Weedaide products (iii) launch very quickly and sell through multiple channels soon. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation: changes in law; the ability to implement business strategies and pursue business opportunities; the state of the capital markets; the availability of funds and resources to pursue operations; decline of reimbursement rates; dependence on few payors; possible new drug discoveries; a novel business model; dependence on key suppliers; granting of permits and licenses in a highly regulated business; competition; changes in healthcare regulations or insurance coverage, particularly those relating to mental health or younger citizens; difficulty integrating newly acquired businesses; the time, outcome and cost of any inquiries, audits or litigation with insurance providers, or federal, state or local regulators; low profit market segments; as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company's disclosure documents  filed with the securities regulatory authorities in certain provinces of Canada and available at www.sedar.com. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. The Company's results and forward-looking information and calculations may be affected by fluctuations in exchange rates. All figures are in Canadian dollars unless otherwise indicated.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

BLVD Centers Corporation
Chris Heath
Chief Executive Officer
(424) 372-1123
investor@blvdir.com  
www.BLVDir.com

GlobeNewswire
globenewswire.com

Last updated on: 15/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.